Hospital procurement analysis | Bidding report of hematology analysis equipment from January to October 2023
Overrall Situation
According to statistics, from January to October 2023, a total of 3424 pieces of hematology analysis equipment bidding data were collected, involving 1992 purchasing units and 157 brand owners
Subdivided variety
According to the winning results, the number of winning bids of blood cell analyzer was the largest, followed by coagulation analyzer and flow cytometer.
Figure 1. Distribution of the number of winning bids for subdivided varieties of hematology analysis equipment from January to October 2023 (unit: pieces)
Bid winning trend
Changes in the market size of hematology analysis equipmen bidding in each quarter in 2023 were as follows: The total amount of hematology analysis equipment winning bids from January to October 2023 increased by 9.1% over the same period last year; The total number of bids increased by 3.0% over the same period last year.
Figure 2. The bidding trend of hematology analysis equipment in 2023
Brand and model analysis
According to the disclosed brand and amount data, from January to October of 2023, BD BECTON ranked first, with 20.1% of the total bid amount. Mindray ranked second, with 19.7% of the total bidding amount; BECKMAN ranked third, with 11.2% of the total award.
Figure 3 Top10 Hematology analysis Equipment brands from January to October 2023
| Ranking | Brand | Proportion of General Amount | Quantity Proportion |
| 1 | BD BECTON | 20.1% | 4.1% |
| 2 | MINDRAY | 19.7% | 31.6% |
| 3. | BECKMAN | 11.2% | 3.7% |
| 4. | SYSMEX | 8.9% | 9.9% |
| 5. | AGILENT | 6.1% | 2.4% |
| 6. | CYTEK | 3.6% | 0.5% |
| 7 | AIKANG | 3.5% | 1.4% |
| 8 | DYMIND | 1.9% | 6.4% |
| 9. | Standard
|
1.7% | 0.1% |
| 10 | CYTEK | 1.6% | 0.4% |
In terms of model, from January to October 2023, Mindray’s BC-7500[NR] CS hematology analysis equipment rankeed first with 3.4% of the total award, followed by Bekeman’s CytoFLEX SRT with 3.2% of the total award, and Bidi ranked third with BD BECTON ‘s FACSLyric. The total bidding amount accounted for 2.8%.
Figure 4. Hematology analysis equipment brand and model ranking (Top10) from January to October 2023
| Ranking | Brand+ | Specifications and Models | Percentage of Total Amount | Quantity Proportion |
| 1 | MINDRAY | BC-7500[NR] CS | 3.4% | 4.4% |
| 2 | BECKMAN | CytoFLEX SRT | 3.2% | 0.5% |
| 3. | BD BECTON | FACSLyric | 2.8% | 0.7% |
| 4. | SYSMEX | XN-10x | 2.6% | 2.2% |
| 5. | BECKMAN | CytoFLEX LX | 2.1% | 0.4% |
| 6. | CYTEK | Aurora | 1.9% | 0.2% |
| 7 | BECKMAN | CytoFLEX S | 1.9% | 0.6% |
| 8 | BECKMAN | CytoFLEX | 1.8% | 1.0% |
| 9. | BD BECTON | FACSymphony A3 | 1.7% | 0.1% |
| 10 | MINDRAY | CAL7000 | 1.6% | 0.8% |
Regional market
According to the winning results, the most active bidding area for hematology analysis equipment from January to October 2023 was mainly in Shanghai, accounting for 11.1%; Guangdong Province came in second with 9.3 percent. Zhejiang Province ranked third with 7.7 percent.
Figure 5 Region Ranking of winning bids for hematology analysis equipment in provinces (autonomous regions and municipalities directly under the Central Government) from January to October 2023 (Unit: ten thousand yuan)
| Ranking | Provinces | Amount proportion | Quantity Proportion |
| 1 | Shanghai | 11.1% | 4.0% |
| 2 | Guangdong | 9.3% | 9.1% |
| 3. | Zhejiang | 7.7% | 5.3% |
| 4. | Jiangsu | 7.0 | 5.8% |
| 5. | Anhui | 5.0% | 7.2% |
| 6. | Beijing | 4.8% | 2.8% |
| 7 | Jiangxi | 4.5% | 3.7% |
| 8 | Hubei | 4.4% | 5.3% |
| 9. | Fujian | 4.0% | 3.5% |
| 10 | Sichuan | 3.8% | 4.5% |
Ranking of tenderers
According to the winning result, the bidding unit with the highest amount of hematology analysis equipment purchase from January to October 2023 was Tongji University, Zhejiang University ranked second, and Guizhou Medical University rankeed third.
Figure6. Hematology Analysis Equipment Procurement Ranking of national tendering units from January to October 2023 (Top10)
| Ranking | Winning bidders | location | Proportion of
Procurement Amount |
Quantity Proportion
|
| 1 | Tongji University | Shanghai | 3.1% |
0.5%- |
| 2 | Zhejiang University | Zhejiang Province | 1.3% | 0.2% |
| 3. | Guizhou Medical University | Guizhou Province | 1.3% | 0.3% |
| 4. | The First Affiliated Hospital of Soochow University | Jiangsu
Province |
1.1% | 0.2% |
| 5. | Dongnan University | Jiangsu
Province |
1.0% | 0.2% |
| 6. | Puning Municiple People’s Hospital | Guangdong
Province |
0.9% | 0.4% |
| 7 | The First Affiliated Hospital of Nanchang University | Jiangxi Province | 0.9% | 0.1% |
| 8 | The First Affiliated Hospital of China Medical University | Liaoning
Province |
0.8% | 0.2% |
| 9. | Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS) | Guangdong
Province |
0.8% | 0.1% |
| 10 | Fudan University | Shanghai | 0.7% | 0.1% |
Ranking of tenderers
According to the winning result, the bidding unit with the highest amount of hematology analysis equipment purchase from January to October 2023 was Tongji University, Zhejiang University ranked second, and Guizhou Medical University ranked third.
Figure 8. Top10 Sales of hematology analysis equipment from January to October 2023
| Ranking | Winning bidders | Percentage of sales | Quantity Proportion
|
Proportion of dealer performance |
| 1 | Chengdu YOUNG-SUN IMP.& Exp.trade Co., Ltd. | 1.3% | 0.3% | 72.4% |
| 2 | Guangdong Zhongke Import and Export Co., Ltd. | 1.2% | 0.3% | 5.8% |
| 3. | Jiangsu SUMEC Medical Technology Co., Ltd | 1.1% | 0.2% | 51.9% |
| 4. | China Pharmaceutical Group Shanghai Medical Instrument Co.,ltd | 1.0% | 0.2% | 22.1% |
| 5. | Guangzhou Aoyi Import and Export Co., Ltd | 0.9% | 0.1% | 18.8% |
| 6. | Jiangsu Yuansu Biological Science Instrument Co., Ltd | 0.8% | 0.2% | 98.2% |
| 7 | Hangzhou Yidan Biotechnology Co.,Ltd | 0.7% | 0.1% | 32.6% |
| 8 | Henan Benchun Trading Co., Ltd | 0.7% | 0.1% | 100.0% |
| 9. | Shanghai Univ -bio. Technology Co., Ltd | 0.7% | 0.2% | 44.5% |
| 10 | CHINA NATIONAL HEAVY MAKINERY CORPORATION | 0.7% | 0.1% | 100.0% |
Note: The proportion of performance of the winning bidder refers to the proportion of sales of hematological analysis equipment to the total sales of the winning bidder.
China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com
Source：JOINCHAIN, MDCLOUD
Translated & edited： Bradyknow
